Biotechnology Assets, S.A. (BME: BST)
Health Care · Biotechnology · ES
€0.20
+6.85% today · -46.0% 1Y
Biotechnology Assets, S.A. (BME: BST) operates in the Biotechnology industry within the Health Care sector. The company is valued at $16.39M and employs 26 people.
Over the last twelve months the share price has lost 46.0%, trading between 0.18 and 0.38.
Tweenvest scores Biotechnology Assets, S.A. across four factors: quality 57/100, value 77/100, growth 84/100. Its strongest factor is growth.
BST price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.39M
- Revenue (TTM)
- $4.03M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 2.10
- 52-week high
- €0.38
- 52-week low
- €0.18
- Avg volume (3M)
- —
- Shares outstanding
- 75.07M
- Employees
- 26
- Next earnings
- —
About Biotechnology Assets, S.A.
Biotechnologies Assets S.A. is dedicated to conceiving, producing, and commercializing sophisticated biotechnological assets. These innovative materials are utilized across a diverse array of sectors, including biopharmaceuticals, agriculture, cosmetics, animal health, and the broader chemical industry. The company operates globally, with its headquarters located in Cádiz, Spain, where it was established in 1954.
- ISIN
- ES0184980003
- Listed since
- Jan 26, 2012
- Exchange
- Bolsas y Mercados Espanoles
- Currency
- EUR
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Daesung Microbiological Labs. Co., Ltd.KOSDAQ: A036480 | $16.50M | ₩5,790.00 | -3.50% |
| Vectorite Biomedical Inc.TPEX: 4170 | $16.46M | NT$12.20 | -2.79% |
| Shaperon Inc.KOSDAQ: A378800 | $16.44M | ₩2,370.00 | -11.57% |
| Bioray Biotech Co., LtdTPEX: 7561 | $16.41M | NT$18.00 | -3.23% |
| aTyr Pharma, Inc.NasdaqCM: ATYR | $16.19M | $0.17 | -2.88% |
| Psyence Biomedical Ltd.NasdaqCM: PBM | $16.10M | $4.22 | -15.09% |
| TScan Therapeutics, Inc.NasdaqGM: TCRX | $15.66M | $0.23 | -2.94% |
| Onco-Innovations LimitedCNSX: ONCO | $15.60M | CA$0.32 | -13.51% |
Figures last refreshed Oct 18, 2026.